Key result
Coronary artery calcification score (CACS) was associated with progression to renal replacement therapy in non-dialysis CKD patients, whereas IACS was not.
Why the study?
While Agatston's coronary artery calcification score (CACS) is validated for assessing vascular calcification in CKD, this study aimed to evaluate both CACS and the common iliac artery calcification score (IACS) and examine the variables and renal outcomes related to each score.
Are coronary artery calcification score (CACS) and common iliac artery calcification score (IACS) associated with CKD-related risk factors and progression to renal replacement therapy in non-dialysis CKD patients?
Cohort (n=145)
No
Are coronary artery calcification score (CACS) and common iliac artery calcification score (IACS) associated with CKD-related risk factors and progression to renal replacement therapy in non-dialysis CKD patients?
Answers are grounded in this paper and cite their sources.
In non-dialysis CKD patients, coronary artery calcification score (CACS), unlike common iliac artery calcification score (IACS), is independently associated with CKD-specific risk factors (lower eGFR and hyperphosphataemia) and predicts progression to renal replacement therapy.
AIM: Many studies have validated Agatston's coronary artery calcification score (CACS) for assessing vascular calcification (VC) in chronic kidney disease (CKD) patients. This study aimed to evaluate the CACS and common iliac artery calcification score (IACS) and to examine the variables related to each score. METHODS: The subjects were 145 non-dialysis CKD patients. The CACS and IACS were determined using the same thoracicoabdominal multi-detector computed tomography. Multiple regression analyses were performed to assess the factors associated with the CACS or IACS. The associations between progression to renal replacement therapy (RRT) and the CACS or IACS were studied using Cox hazards models. Age, diabetes, the serum phosphate level, and the eGFR were found to be significant factors of the CACS [β (95% CI): 0.38 (0.02-0.04), P < 0.0001, 0.28 (0.19-0.50), P < 0.0001, 0.16 (0.03-0.45), P < 0.05 and -0.15 (-0.02-0.00), P < 0.05, respectively]. Age and diabetes were shown to be significant factors of the IACS [β (95% CI): 0.53 (0.04-0.06), P < 0.0001, and 0.18 (0.07-0.40), P < 0.01, respectively]. Progression to RRT occurred in 31 patients and was significantly associated with the CACS (hazard ratio: 1.01, P < 0.01), urinary protein level and eGFR, but not the IACS. CONCLUSION: Chronic kidney disease related risk factors for VC, such as the eGFR and hyperphosphataemia, are significantly associated with a high CACS, but not a high IACS, and the CACS is a significant predictor of progression to RRT.
No takes yet. Share an insight, caveat, or question.
Mizuiri et al. (2017) conducted a cohort in Non-dialysis chronic kidney disease (CKD grade 2-5) (n=145). Coronary artery calcification score (CACS) and common iliac artery calcification score (IACS) via thoracicoabdominal MDCT was evaluated on Progression to renal replacement therapy (RRT; chronic dialysis initiation or transplantation) (HR 1.01, 95% CI 1.00-1.02, p=<0.01). Coronary artery calcification score (CACS) was associated with progression to renal replacement therapy in non-dialysis CKD patients, whereas IACS was not.
Synapse has enriched 10 related papers. Consider them for comparative context: